HMP provides safe and reliable preservation of “orphan” livers

In a study of 31 adult ECD livers that were declined by the originating UNOS region, Guarrera et al sought to determine whether the use of HMP could reduce the incidence and clinical impact of classic preservation injuries. They compared these livers to a historic group of ECD SCS donors in a matched cohort. They found that there were:

  • Fewer incidents of EAD in the HMP group (p=0.384)
  • Significantly less biliary complications in the HMP group (p=0.016)
  • Significantly shorter hospital lengths of stay in the HMP group (p=0.001)

Overall, they found that HMP provided safe and reliable preservation of SCS ECD livers that were deemed “orphan” based on their decline from the originating UNOS region.

Read the full article here:

The Latest

Check out the most recent posts

Fox19—UC Health Performs First Cold Pump Liver Transplant

In this article from FOX19 NOW, meet the first liver transplant patient to receive a cold pump liver which was pumped on a LifePort® Liver Transporter during its clinical trial, PILOT™. PILOT (Perfusion to Improve Liver Outcomes in Transplantation) is a...

ABC12 News—Organ Transplant Goes Hi-tech

In this article, Intermountain Healthcare takes part in the PILOT™ clinical trial of the LifePort® Liver Transporter. PILOT (Perfusion to Improve Liver Outcomes in Transplantation) is a prospective randomized multi-center oxygenated hypothermic machine...

KSLTV—Doctors Testing New Liver Transplant Transport System

In this article, KSLTV of Salt Lake City reports on Intermountain Healthcare’s participation in the LifePort Liver Transporter clinical trial. “We’re keeping that liver working in a somewhat normal, physiologic state during the time that it’s out of the donor’s body...